BackOryzon Genomics S.A. Overview

Oryzon Genomics S.A. Other Current Assets

Track Oryzon Genomics S.A.'s other current assets ($3.4K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$3384.00
↓ 99.73% YoYΔ $-1.25M vs prior year quarter

Peer average / median

Loading

Oryzon Genomics S.A. Other Current Assets History

Loading

Oryzon Genomics S.A. vs. peers: Other Current Assets Comparison

Loading

Oryzon Genomics S.A. Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Oryzon Genomics S.A. (ORY.MC) FAQ

Oryzon Genomics S.A. (ORY.MC) currently reports a other current assets of $3.4K as of June 2026. That compares with $1.2M in the prior-year period — down 99.7% year over year. Use the charts on this page to explore Oryzon Genomics S.A.'s other current assets history and peer comparisons.

Oryzon Genomics S.A.'s other current assets decreased from $1.2M to $3.4K — a 99.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Oryzon Genomics S.A. reported $3.4K in other current assets as of June 2026. That compares with $1.2M in the prior-year period — down 99.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $3.4K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Oryzon Genomics S.A., and consider following ORY.MC for alerts when major investors trade the stock.

Oryzon Genomics S.A. is classified in the Healthcare sector. On other current assets, it currently shows $3.4K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ORY.MC with unrelated industries.